ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,499,385 | +9.3% | 632,808 | +10.2% | 0.19% | +12.0% |
Q2 2023 | $38,877,118 | +3867.8% | 574,171 | +3070.3% | 0.17% | +3220.0% |
Q1 2023 | $979,805 | -94.6% | 18,111 | -94.1% | 0.01% | -95.5% |
Q4 2022 | $18,249,765 | +934.0% | 305,129 | +681.9% | 0.11% | +909.1% |
Q3 2022 | $1,765,000 | -73.3% | 39,025 | -58.1% | 0.01% | -68.6% |
Q1 2022 | $6,621,000 | -19.3% | 93,108 | -26.0% | 0.04% | -18.6% |
Q4 2021 | $8,209,000 | +6.9% | 125,788 | +22.9% | 0.04% | +2.4% |
Q3 2021 | $7,680,000 | +36.7% | 102,345 | +42.1% | 0.04% | +31.2% |
Q2 2021 | $5,619,000 | +60.6% | 72,006 | +68.6% | 0.03% | +45.5% |
Q1 2021 | $3,498,000 | +189.6% | 42,715 | +192.4% | 0.02% | +175.0% |
Q4 2020 | $1,208,000 | +100.0% | 14,609 | +57.2% | 0.01% | +60.0% |
Q3 2020 | $604,000 | +40.8% | 9,295 | +34.3% | 0.01% | +25.0% |
Q2 2020 | $429,000 | +19.2% | 6,921 | +21.9% | 0.00% | -20.0% |
Q2 2019 | $360,000 | – | 5,678 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |